2-(1,2,3,4-Tetrahydroquinolin-1-yl)acetonitrile, 95+%, 50mg

9-Propyl-9H-carbazole, 95%, 50g

Hydroxyvalerenic acid, with analyt. Documents, 50 mg, glass packaging

(1S)-1-(5-Chloropyridin-2-yl)ethan-1-amine dihydrochloride, 97%, 100mg

4-Chloro-1H-pyrrolo[2,3-c]pyridine, 95.0%, 1g

Tetrahydrofuran-2-carboximidamide hydrochloride, 97.0%, 250mg

3-(Diphenylmethylene)-1,1-diethyl-2-methylpyrrolidin-1-ium bromide, 95.0%, 250mg

(2E)-1-(2-chlorophenyl)-3-(4-chlorophenyl)prop-2-en-1-one, 95.0%, 10g

1-[(aminooxy)methyl]-4-chlorobenzene, 95.0%, 1g

4-Methyl-1-oxo-1,3-dihydroisobenzofuran-5-yl trifluoromethanesulfonate, 97%, 100mg

1-Cbz-(2R)-Methylpiperazine, 97.0%, 100g

4,4'-Bis[4-(di-p-tolylamino)styryl]biphenyl>98.0%(HPLC)200mg

3-Bromo-5-methyl-1,2,4-oxadiazole, 95.0%, 1g